Literature DB >> 8604014

Regulated expression of a 16-kd galectin-like protein in activated rat macrophages.

G Rabinovich1, L Castagna, C Landa, C M Riera, C Sotomayor.   

Abstract

We investigated the presence of a galectin-like protein in rat mononuclear cells using a polyclonal antibody raised against a soluble lactose-binding lectin purified from adult chicken liver that immunoreacted strongly with a broad protein band of about 16 kd in Western blot assays. Immunochemical studies revealed a constitutive expression of this protein in mononuclear cells mainly in the macrophage (M phi) population. Subcellular localization was assessed by Western blot assays of the cytosolic and membrane fractions of different cell populations studied: (1) spleen mononuclear cells, (2) T cell-enriched, (3) B cell- and M phi-enriched populations, and (4) peritoneal cells, processed in the presence of lactose. In broad agreement with immunocytochemical studies of nonpermeabilized and permeabilized cells, Western blot assays suggest that this protein is localized mainly in the cytoplasmic compartment but also associated with the cell surface. By flow cytometric analyses we detected about a 14% of ED1 double-positive cells corresponding to macrophages that constitutively express this galectin-like protein associated with their cell surface. The cytosolic fraction obtained from the M phi-enriched cell population showed hemagglutinating activity specifically inhibited by beta-galactoside-related sugars. Moreover, this galectin-like protein was retained in a lactosyl-Sepharose matrix and specifically eluted with lactose. In this work, evidence is also provided to show that different stimuli are able to modulate the expression of the galectin-like protein. Expression was upregulated in inflammatory and activated macrophages, revealing a significant increase in phorbol ester- and formylmethionine oligopeptide-treated cells. Both stimuli involving protein kinase C activation pathway have been able not only to up-regulate the total expression of this protein but also to modulate its subcellular localization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604014     DOI: 10.1002/jlb.59.3.363

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

Review 1.  Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses.

Authors:  Gabriel A Rabinovich; Marta A Toscano; Juan M Ilarregui; Natalia Rubinstein
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 2.  Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity.

Authors:  Juan P Cerliani; Sean R Stowell; Iván D Mascanfroni; Connie M Arthur; Richard D Cummings; Gabriel A Rabinovich
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

3.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

4.  Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival.

Authors:  E Zúñiga; A Gruppi; J Hirabayashi; K I Kasai; G A Rabinovich
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1.

Authors:  G A Rabinovich; A Ariel; R Hershkoviz; J Hirabayashi; K I Kasai; O Lider
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

6.  Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase.

Authors:  Mercedes B Fuertes; Luciana L Molinero; Marta A Toscano; Juan M Ilarregui; Natalia Rubinstein; Leonardo Fainboim; Norberto W Zwirner; Gabriel A Rabinovich
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

7.  Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease.

Authors:  L Giordanengo; S Gea; G Barbieri; G A Rabinovich
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

8.  Oral administration of oleic or linoleic acids modulates the production of inflammatory mediators by rat macrophages.

Authors:  Juliana Magdalon; Marco A R Vinolo; Hosana G Rodrigues; Vivian A Paschoal; Rosângela P Torres; Jorge Mancini-Filho; Philip C Calder; Elaine Hatanaka; Rui Curi
Journal:  Lipids       Date:  2012-06-14       Impact factor: 1.880

9.  A Pro-resolving Role for Galectin-1 in Acute Inflammation.

Authors:  Hannah L Law; Rachael D Wright; Asif J Iqbal; Lucy V Norling; Dianne Cooper
Journal:  Front Pharmacol       Date:  2020-03-20       Impact factor: 5.810

10.  Glycosylation-dependent galectin-receptor interactions promote Chlamydia trachomatis infection.

Authors:  Agustin L Lujan; Diego O Croci; Julián A Gambarte Tudela; Antonella D Losinno; Alejandro J Cagnoni; Karina V Mariño; María T Damiani; Gabriel A Rabinovich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.